These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

721 related items for PubMed ID: 1282774

  • 1. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
    Mori Y, Shima H, Ihara H, Yabumoto H, Iwasaki A, Yoshioka M, Ikoma F.
    Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
    [Abstract] [Full Text] [Related]

  • 2. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
    Kumano M, Miyake H, Hara I, Muramaki M, Takenaka A, Fujisawa M.
    Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U, Bamberg M, Engert J, Gnekow AK, Haas HJ, Jürgens H, Kühl J, Lenard HG, Lumenta C, Niethammer D.
    Klin Padiatr; 1991 Dec; 203(4):236-45. PubMed ID: 1719267
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89].
    Göbel U, Calaminus G, Teske C, Bamberg M, Bökkerink JP, Haas RJ, Holschneider AM, Janka-Schaub G, Jürgens H, Mittler U.
    Klin Padiatr; 1993 Dec; 205(4):231-40. PubMed ID: 7690864
    [Abstract] [Full Text] [Related]

  • 8. [Advanced germinal tumors of the testicle: clinical experience with cisplatin, bleomycin and vinblastine (PVB) or etoposide (BEP)].
    Alonso Curbera G, González-Manzano R, Aramendía Beitia JM, Martínez Monge R, Agüera Fernández L, Rebollo Liceaga J.
    Rev Med Univ Navarra; 1993 Dec; 38(1):13-8. PubMed ID: 8711305
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
    Ikeda I, Shuin T, Yao M, Kubota Y, Hosaka M.
    Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
    [Abstract] [Full Text] [Related]

  • 11. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S, Kramar A, Théodore C, Geoffrois L, Chevreau C, Biron P, Nguyen BB, Héron JF, Kerbrat P, Caty A, Delva R, Fargeot P, Fizazi K, Bouzy J, Droz JP, Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    J Clin Oncol; 2008 Jan 20; 26(3):421-7. PubMed ID: 18202419
    [Abstract] [Full Text] [Related]

  • 12. [BEP-chemotherapy in patients with testicular tumors--is it worthwhile?].
    Hess U, Jungi WF, Morant R, Schmid L, Senn HJ, Bandhauer K.
    Schweiz Med Wochenschr; 1990 Dec 08; 120(49):1883-6. PubMed ID: 1702233
    [Abstract] [Full Text] [Related]

  • 13. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
    Haugnes HS, Laurell A, Stierner U, Bremnes RM, Dahl O, Cavallin-Ståhl E, Cohn-Cedermark G.
    Acta Oncol; 2012 Feb 08; 51(2):168-76. PubMed ID: 22175254
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
    Westermann DH, Schefer H, Thalmann GN, Karamitopoulou-Diamantis E, Fey MF, Studer UE.
    J Urol; 2008 Jan 08; 179(1):163-6. PubMed ID: 18001800
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy for advanced testicular cancer.
    Fox EP, Loehrer PJ.
    Hematol Oncol Clin North Am; 1991 Dec 08; 5(6):1173-87. PubMed ID: 1723407
    [Abstract] [Full Text] [Related]

  • 17. [The chemotherapy of nonseminomatous testicular tumors].
    Tiuliandin SA, Bulanov AA, Titov DA, Sokolov AV, Sholokhov VN, Garin AM.
    Urol Nefrol (Mosk); 1996 Dec 08; (2):26-9. PubMed ID: 8677548
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel+BEP (T-BEP) regimen as induction chemotherapy in poor prognosis patients with nonseminomatous germ cell tumors: a phase II study.
    Tryakin A, Fedyanin M, Kanagavel D, Fainstein I, Sergeev J, Polockij B, Matveev V, Zakharova T, Garin A, Tjulandin S.
    Urology; 2011 Sep 08; 78(3):620-5. PubMed ID: 21764427
    [Abstract] [Full Text] [Related]

  • 19. [PVB therapy for advanced testicular cancer].
    Nakao M, Nakagawa S, Toyoda K, Nukui M, Takada H, Ebisui K, Sugimoto K, Watanabe H, Maegawa M, Miyakoda K.
    Hinyokika Kiyo; 1989 Nov 08; 35(11):1871-5. PubMed ID: 2482672
    [Abstract] [Full Text] [Related]

  • 20. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
    Jeremić B, Djurić Lj, Djordjević S, Cirović V, Milojević Lj, Stanisavljević B, Matović M, Mijatović Lj.
    Srp Arh Celok Lek; 1994 Nov 08; 122(9-10):257-9. PubMed ID: 17977429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.